Runs an online marketplace where researchers buy human biospecimens.
Jun 2026Revenue $466K/yrExpenses $9.89M/yr
No trendCash runway ≈ 8 months from Jun 2026
Figures by year
When will iSpecimen be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $466K and expenses $9.89M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.93M | $10.9M | −$8.98M |
| Dec 2024 | $9.29M | $22.0M | −$12.7M |
| Dec 2023 | $9.93M | $21.1M | −$11.2M |
| Dec 2022 | $10.4M | $20.6M | −$10.2M |
| Dec 2021 | $11.1M | $17.1M | −$5.93M |
| Dec 2020 | $8.18M | $10.6M | −$2.41M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.